MARKET

QNRX

QNRX

Quoin Pharmaceuticals Ltd
NASDAQ
8.40
+0.13
+1.57%
After Hours: 8.31 -0.09 -1.07% 18:58 02/13 EST
OPEN
8.12
PREV CLOSE
8.27
HIGH
8.44
LOW
8.12
VOLUME
3.68K
TURNOVER
--
52 WEEK HIGH
41.80
52 WEEK LOW
5.01
MARKET CAP
13.58M
P/E (TTM)
-0.0121
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at QNRX last week (0202-0206)?
Weekly Report · 4d ago
Weekly Report: what happened at QNRX last week (0126-0130)?
Weekly Report · 02/02 10:21
Quoin Pharmaceuticals Submits Orphan Drug Designation Application To Japan's MHLW For QRX003 To Treat Netherton Syndrome
Benzinga · 01/27 13:37
Quoin announces submission to Japanese MHLW for ODD for QRX003
TipRanks · 01/27 13:36
Weekly Report: what happened at QNRX last week (0119-0123)?
Weekly Report · 01/26 10:21
Quoin seeks Saudi breakthrough status for Netherton therapy
TipRanks · 01/20 22:49
Quoin files Breakthrough Medicine Designation with SFDA for QRX003
TipRanks · 01/20 13:46
Quoin Pharmaceuticals Submits Application For Breakthrough Medicine Designation With Saudi Food And Drug Authority For QRX003 To Treat Netherton Syndrome
Benzinga · 01/20 13:35
More
About QNRX
Quoin Pharmaceuticals Ltd, former Cellect Biotechnology Ltd, is an Israel-based specialty pharmaceutical company, focused on developing and commercializing therapeutic products that treat rare and orphan diseases. The Company’s first lead product is QRX003, a once daily, topical lotion comprised of a broad-spectrum serine protease inhibitor, formulated with the proprietary Invisicare technology, to treat Netherton Syndrome. The product going to be developed for other rare dermatological diseases including Peeling Skin Syndrome, SAM Syndrome, and Palmoplantar Keratoderma. Quoin is also developing QRX004 as a potential treatment for Dystrophic Epidermolysis Bullosa, and QRX006 as a potential therapy for an, as of yet, undisclosed rare skin disease.

Webull offers Quoin Pharmaceuticals Ltd - ADR stock information, including NASDAQ: QNRX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, QNRX stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading QNRX stock methods without spending real money on the virtual paper trading platform.